Dr. Jack Regan, CEO of LexaGene, shares his work identifying the future biothreats human and veterinary populations may face. While biothreats may seem like a pending threat for the developing world, there may be a broader goal.
By examining the genome, MiQLab can assist point-of-need genetic testing for contaminants without an infected individual present. By examining the genome, researchers may be able to identify and fight the current threat more effectively by diagnosing first.
